litlas
Log inCreate account

Eva L. Feldman

Active 1988–2025

Also published as
Eva L Feldman
291
Papers
47,982
Citations
122
h-index
278
i10-index

Citations

Citations per year for Eva L. Feldman1989: 2 citations1990: 4 citations1991: 10 citations1992: 6 citations1993: 16 citations1994: 20 citations1995: 24 citations1996: 28 citations1997: 29 citations1998: 66 citations1999: 111 citations2000: 109 citations2001: 110 citations2002: 117 citations2003: 121 citations2004: 187 citations2005: 156 citations2006: 193 citations2007: 181 citations2008: 218 citations2009: 267 citations2010: 243 citations2011: 327 citations2012: 306 citations2013: 415 citations2014: 451 citations2015: 326 citations2016: 342 citations2017: 411 citations2018: 398 citations2019: 1,493 citations2020: 1,765 citations2021: 1,642 citations2022: 1,501 citations2023: 1,242 citations2024: 2,208 citations2025: 1,016 citations2026: 25 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,694 citing papers, 25.3% of this breakdownChina: 1,752 citing papers, 12% of this breakdownUnited Kingdom: 959 citing papers, 6.6% of this breakdownItaly: 739 citing papers, 5% of this breakdownGermany: 617 citing papers, 4.2% of this breakdownAustralia: 492 citing papers, 3.4% of this breakdownCanada: 479 citing papers, 3.3% of this breakdownIndia: 452 citing papers, 3.1% of this breakdownJapan: 362 citing papers, 2.5% of this breakdownFrance: 356 citing papers, 2.4% of this breakdownSpain: 306 citing papers, 2.1% of this breakdownNetherlands: 265 citing papers, 1.8% of this breakdown
0%25.3%Other 28.3%

Institutions

Fields

  • Medicine62.8%
  • Biochemistry, Genetics and Molecular Biology21.4%
  • Neuroscience9%
  • Immunology and Microbiology1.1%
  • Health Professions0.9%
  • Materials Science0.9%
  • Other3.9%

Topics

  • Pain Mechanisms and Treatments5.5%
  • Amyotrophic Lateral Sclerosis Research3.6%
  • Diabetic Foot Ulcer Assessment and Management2.2%
  • Nerve injury and regeneration2.1%
  • Neurogenetic and Muscular Disorders Research1.9%
  • Alzheimer's disease research and treatments1.9%
  • Other82.8%

Coauthors

All papers

Open in search
  1. Amyotrophic lateral sclerosis

    Authors: Eva L. Feldman, Stephen A. Goutman, Susanne Petri, Letizia Mazzini, Masha G. Savelieff, Pamela J. Shaw, Gen Sobue - The Lancet 2022 cited by 1,023

  2. Diabetic Neuropathy: A Position Statement by the American Diabetes Association

    Authors: Rodica Pop‐Busui, Andrew J.M. Boulton, Eva L. Feldman, Vera Bril, Roy Freeman, Rayaz A. Malik, Jay M. Sosenko, Dan Ziegler - Diabetes Care 2016 cited by 2,466

  3. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis

    Authors: Stephen A Goutman, Orla Hardiman, Ammar Al-Chalabi, Adriano Chió, Masha G Savelieff, Matthew C Kiernan, Eva L Feldman - The Lancet Neurology 2022 cited by 440

  4. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

    Authors: Stephen A. Goutman, Orla Hardiman, Ammar Al‐Chalabi, Adriano Chiò, Masha G. Savelieff, Matthew C. Kiernan, Eva L. Feldman - The Lancet Neurology 2022 cited by 385

  5. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments

    Authors: Melissa A. Elafros, Henning Andersen, David Bennett, Masha G. Savelieff, Vijay Viswanathan, Brian C. Callaghan, Eva L. Feldman - The Lancet Neurology 2022 cited by 346

  6. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain

    Authors: Eva L. Feldman, Klaus‐Armin Nave, Troels S. Jensen, David Bennett - Neuron 2017 cited by 887

  7. Diabetic neuropathy: clinical manifestations and current treatments

    Authors: Brian C. Callaghan, Hsinlin T. Cheng, Catherine L. Stables, Andrea L. Smith, Eva L. Feldman - The Lancet Neurology 2012 cited by 1,176

  8. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism

    Authors: Stéphanie Eid, Kelli M. Sas, Steven F. Abcouwer, Eva L. Feldman, Thomas W. Gardner, Subramaniam Pennathur, Patrice E. Fort - Diabetologia 2019 cited by 468

  9. New perspectives in diabetic neuropathy

    Authors: Stéphanie Eid, Amy E. Rumora, Bogdan Beirowski, David Bennett, Junguk Hur, Masha G. Savelieff, Eva L. Feldman - Neuron 2023 cited by 221

  10. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management

    Authors: Troels S. Jensen, Páll Karlsson, Sandra Sif Gylfadottir, Signe T. Andersen, David Bennett, Hatice Tankişi, Nanna Brix Finnerup, Astrid Juhl Terkelsen, Karolina Snopek Khan, Andreas C. Themistocleous, Alexander Gramm Kristensen, Mustapha Itani, Søren H. Sindrup, Henning Andersen, Morten Charles, Eva L. Feldman, Brian C. Callaghan - Brain 2021 cited by 248

  11. Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy

    Authors: Rodica Pop‐Busui, Lynn Ang, Andrew J.M. Boulton, Eva L. Feldman, Robin L. Marcus, Kara Mizokami‐Stout, J. Robinson Singleton, Dan Ziegler - ADA Clinical Compendia 2022 cited by 204

  12. Enhanced glucose control for preventing and treating diabetic neuropathy

    Authors: Brian C. Callaghan, Ann Little, Eva L. Feldman, Richard AC Hughes - Cochrane Database of Systematic Reviews 2012 cited by 579

  13. Neurological consequences of obesity

    Authors: Phillipe D. O’Brien, Lucy M. Hinder, Brian C. Callaghan, Eva L. Feldman - The Lancet Neurology 2017 cited by 540

  14. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

    Authors: Eva L. Feldman, Martin Stevens, P. K. Thomas, Marc B. Brown, N. Canal, D. A. Greene - Diabetes Care 1994 cited by 1,284

  15. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

    Authors: William H. Herman, Rodica Pop‐Busui, Barbara H. Braffett, Cathy Martin, Patricia A. Cleary, James W. Albers, Eva L. Feldman - Diabetic Medicine 2012 cited by 479

  16. Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark

    Authors: Signe T. Andersen, Daniel R. Witte, Else‐Marie Dalsgaard, Henning Andersen, Peter P. Nawroth, Thomas Fleming, Troels Mygind Jensen, Nanna Brix Finnerup, Troels S. Jensen, Torsten Lauritzen, Eva L. Feldman, Brian C. Callaghan, Morten Charles - Diabetes Care 2018 cited by 256

  17. How does diabetes accelerate Alzheimer disease pathology?

    Authors: Catrina Sims‐Robinson, Bhumsoo Kim, Andrew J. Rosko, Eva L. Feldman - Nature Reviews Neurology 2010 cited by 494

  18. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

    Authors: Barbara H. Braffett, Rose Gubitosi‐Klug, James W. Albers, Eva L. Feldman, Catherine L. Martin, Neil H. White, Trevor J. Orchard, Maria F. Lopes‐Virella, John M. Lachin, Rodica Pop‐Busui - Diabetes 2020 cited by 213

  19. Diabetic neuropathy: cellular mechanisms as therapeutic targets

    Authors: Andrea M. Vincent, Brian C. Callaghan, Andrea L. Smith, Eva L. Feldman - Nature Reviews Neurology 2011 cited by 554

  20. Oxidative Stress in the Pathogenesis of Diabetic Neuropathy

    Authors: Andrea M. Vincent, James W. Russell, Phillip A. Low, Eva L. Feldman - Endocrine Reviews 2004 cited by 968

  21. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications

    Authors: Kelli M. Sas, Pradeep Kayampilly, Jaeman Byun, Viji Nair, Lucy M. Hinder, Junguk Hur, Hongyu Zhang, Cheng‐mao Lin, Nathan Qi, George Michailidis, Per‐Henrik Groop, Robert G. Nelson, Manjula Darshi, Kumar Sharma, Jeffrey R. Schelling, John R. Sedor, Rodica Pop‐Busui, Joel M. Weinberg, Scott A. Soleimanpour, Steven F. Abcouwer, Thomas W. Gardner, Charles Burant, Eva L. Feldman, Matthias Kretzler, Frank C. Brosius, Subramaniam Pennathur - JCI Insight 2016 cited by 265

  22. Inflammation as a Therapeutic Target for Diabetic Neuropathies

    Authors: Rodica Pop‐Busui, Lynn Ang, Crystal Holmes, Katherine Gallagher, Eva L. Feldman - Current Diabetes Reports 2016 cited by 255

  23. Diabetic Neuropathies

    Authors: Andrew J.M. Boulton, A Vinik, Joseph C. Arezzo, Vera Bril, Eva L. Feldman, Roy Freeman, Rayaz A. Malik, Raelene E. Maser, Jay M. Sosenko, Dan Ziegler - Diabetes Care 2005 cited by 1,836

  24. Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status

    Authors: Brian C. Callaghan, Rong Xia, Mousumi Banerjee, Nathalie de Rekeneire, Tamara B. Harris, Anne B. Newman, Suzanne Satterfield, Ann V. Schwartz, Aaron I. Vinik, Eva L. Feldman, Elsa S. Strotmeyer - Diabetes Care 2016 cited by 217